Skip to main content
. 2022 Oct 21;7(13):3326–3337. doi: 10.1182/bloodadvances.2022008555

Table 1.

Baseline characteristics of patients with PV vs HCs

Characteristics Group
P value
PV HCs
Patients, N 102 42
Sex
 Female, n (%) 45 (44.1) 17 (40.5) .72
Age, y
 Median (range) 70 (31-85) 71 (66-74) .083
Body mass index, kg/m2
 Mean (SD) 26.0 (3.9) 24.9 (2.4) .34
Smoking
 Current smoker, n (%) 8 (7.8) 1 (2.4) .28
 Former smoker, n (%) 43 (42.2) 13 (31) .35
 Never smoker, n (%) 50 (49) 26 (61.9) .28
 Unknown, n (%) 1 (1) 2 (4.8)
Hypertension
 Yes, n (%) 55 (53.9) 16 (38.1) .1
 No, n (%) 47 (46.1) 26 (61.9) .36
 Unknown, n (%) 0 (0) 0 (0)
Comorbidity index
 Median (range) 1 (0-9) 0 (0-4) .058
 n (%)
  No comorbidities (CCI = 0) 36 (35.3) 22 (52.4) .064
  Low burden (CCI = 1-2) 42 (41.2) 16 (38.1) .85
  Moderate to high (CCI > 2) 24 (23.5) 4 (9.5) .065
Blood test
 Leukocyte, ×109/L
 Median (range) 5.7 (2.5-21.8) 6.2 (4.5-9.4) .15
 Hematocrit, %
 Mean (SD) 42 (4) 43 (3) .037
 Thrombocyte, ×109/L
 Median (range) 309 (113-884) 227 (125-355) <.001
 eGFR
 Mean (SD) 78.2 (16.5) 73.1 (13.2) .14

CCI, Charlson Comorbidity Index; eGFR, estimated glomerular filtration rate; SD, standard deviation.

Pairwise Wilcoxon rank sum test.

Analysis of variance with post hoc Tukey honest significant difference test.

Comorbidity scores were calculated using CCI.